Interested in stem cell developments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great find.
Showing on youtube at 6pm today:
Dr. Yo, M.D., M.P.H.
@YoDoctorYo
The legend Dr. Javitt from @NeuroRxPharma is joining me to discuss trial data #Aviptadil #RLFTF $RLFTF on Thursday February 11 at 9am EST
What would you do with a patient who was unarmed?
Am I indulging in wishful thinking or is it possible Reddit and Robinhood are keeping an eye on this...........not as a stock to falsely push up but as one still with great potential but currently being misunderstood.
I am going out on a limb here to make the observation that the lack of a conference has not seemed to have hurt the SP.
I am not saying they should spike the pps rather acknowledging that if they get an EUA they will have a narrow window to PR it and that will produce a surge that they should be ready to take advantage of in a way that will keep it going.
If they have big news ready to go they should wait until Monday to release it and have all jets
at full throttle at that time. No need for a weekend of wild speculation with time for traders
to plan tactics and manipulations.
That was 12/30/20. Today is 2/3/21
Especially the Orange ones.
OMG!!! I WAS RIGHT!!!
VanBit,
RT is doing and not doing several things to allow us to keep buying cheap shares giving us a much
better chance of buying low and selling high. The EXCITEMENT is then much greater when the SP rockets up.
Great point.
Is Vanilla aware of this?
Are we moving into another amazing surge to close out the week?
LOOK AT THIS RALLY. IT IS NOW CLEAR THAT WORD HAS GOTTEN OUT THAT RELIEF THERAPEUTICS HAS PUT TOGETHER ONE HELL OF A PR TEAM.
WHAT RELIEF SHOULD DO IS HIRE A VARY LARGE NUMBER OF TOP NOTCH PROFESSIONALS IN PR AND SET UP ONE OF THE WORLD'S BEST PR DEPTS. IF THEY HAVE TO FIRE A LARGE NUMBER OF THE RESEARCH AND MEDICAL PEOPLE TO DO THAT AND DE-EMPHASIZE THE WORK ON RLF100 AND ZYESAMI THEN THAT IS WHAT THEY MUST DO SINCE CLEARLY PR IS WHERE THE ACTION IS. REMEMBER ZZZZ BEST.
Here is the most important Vanbit statement in this post:
"PATENT IS FREELY BEING VIOLATED IN INDIA - TRUTH"
This will be hard to deal with. We must get Trump to threaten a nuclear attack on India if
this is continued.
[I know Biden is now the President but he is less like to issue a threat like this than Trump.)
I know some people in Ulan Bator who know RLF/ZYESAMI exists but what does it matter, the FDA doesn't know they exist.
What are the chances of a late afternoon rally?
Almost a third of recovered Covid patients return to hospital in five months and one in eight die
https://news.yahoo.com/almost-third-recovered-covid-patients-180255388.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
NO! Excellent point.
Are we going to see another late day rally?
Bradykinins also.
Good to see this statement by Vanilla Fitbit. I am going to have a vanilla yogurt right now.
The friendly piano player over at the local lounge is the one who said: "Don't shoot the messenger."
tradinplaces, with you pointing the way I have now figured out how to create money out of thin air
using my keyboard F keys. Send your account numbers ASAP.
I will also out of the kindness of my own heart help any others here who send me their account numbers ASAP.
tradinplaces, I have a couple of keys here I can stroke. Could you let the Fed know I am quite willing to help them with that burdensome task of creating money out of thin air. Thanks in advance.
Does anyone know of any COVID treatment programs in the Boston-Worcester, Massachusetts area
hospitals that are utilizing RLF100 (Aviptadil, Zyesami) for any of their patients.
I am not asking because of any emergency COVID case but for future reference should I or others I know get COVD. Thanks in advance.
I will express the same thanks and praise to J.-Belfort and add that sales profits of "85% Europe/ 80% rest of the world" could be extremely significant since Aviptadil (Zyesami) will, relatively speaking, be a good bit cheaper to produce as well as being much easier to distribute to any part of the world including to the rural and remote areas of the world.
Yes, if the unblinded data is as good as we hope and expect the most important part of this news release will be:
“No drug-related serious adverse events have been reported as of today.”
On prinicple I am opposed to doing this but enough is enough so I am placing Vanitbit on Ignore.
Banbit, main stream media exposure is a minimal factor here and is not something RLF, etc., should be pursuing. You and the rest of us can try to help with that, among others. The FDA knows all about RLF and my guess is RLF and the FDA know they are in difficult territory given that RLF is a tiny company and if the FDA gives them the go ahead that puts them right in Pfizer and Big Pharma territory. There is great pressure there and the FDA may understandably want to be very sure they are doing the right thing since they know the forces that could be launched against any bad judgments they make.
If you were in charge of RLF PR you would be annoying the hell out of the FDA probably resulting in greater delays because of that even if they were happy with the data (even though they should be above such responses). Also, not that many more doctors world wide would know about RLF and that doesn't matter so much because the FDA does know about it.
Further, RLF shouldn't be open to the general public about everything. They are walking a delicate walk on the edge of Big Pharma status. They should focus above all on being open and honest with the FDA. I think they are doing that. They know they have the right stuff and handling it correctly in working closely with the FDA will produce enormous benefits to mankind and to share holders.
They also know that a PR campaign like the one you want could trash or slow down their success. I also am going to suggest that RLF and the FDA are not all that impressed with ALL CAPS PRs which you seem to think would seize the day. Of course, I could be wrong and maybe RLF should also break new ground by moving to ALL CAPS press releases in the future. No doubt, that would force Pfizer, Moderna, AstraZeneca, etc., etc. to follow in kind and via this great PR victory everyone would be made aware that RLF was the real leader in dealing with COVID19.
Vanbit, you never look at or consider where this company was a year ago and the fact that from that point they have already made very considerable achievements. If an EUA comes through in the next couple of weeks the RLF achievements will be, in truth, almost unbelievable.
But we won't worry because we know you will not be deterred in blasting away at them for taking so long.
So Vanbit, what are you going to say if the EUA comes through in the next couple of weeks?
Relief Therapeutics sees lead drug data from pivotal COVID-19 study early next month
https://seekingalpha.com/news/3644184-relief-therapeutics-sees-lead-drug-data-from-pivotal-covidminus-19-study-early-next-month
For the near term it will be availability in the region one is in. No way around that for now. Over time and with experience they should be able to adapt availability based on whatever they learn about which vaccines work best for which type patients.
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
https://cnb.cx/2Wb0G9t